Dr. Manochakian discusses the implications of recent phase 3 trials in lung cancer. Dr. Manochakian discusses the most pressing unanswered questions in lung cancer and how they could be addressed. Dr. Manochakian reflects on progress in lung cancer treatment and why it's critical to bring it to the community setting. Dr. Manochakian shared his insights during the Oncology Brothers Advancements in Oncology event. Dr. Rami Manochakian and The Oncology Brothers discusses treatment for SCLC, which is evolving at a rapid pace. Dr. Manochakian discusses new data and why next-generation sequencing is a critical step when treating NSCLC. Dr. Ugurlu said the event was an inspiring experience that helped him navigate the latest data in oncology. The Oncology Brothers and Dr. Manochakian discussed the rapid changes in the perioperative treatment landscape for NSCLC. Dr. Halmos discusses how the Advancements in Oncology event helped unpack the new data for community oncologists. Dr. Singhi discusses the event held by The Oncology Brothers during the American Society of Clinical Oncology Annual Meeting. Rami Manochakian, MD, FASCO, shared his insights on key lung cancer updates during the event. Advancements in Oncology, an innovative, panel-based event focused on 4 key areas of cancer, is a can't-miss event. The Oncology Brothers talk with Paolo Tarantino, MD, about the TROPiCS-02 study presented at SABCS. Will HER2CLIMB-02 study data impact the breast cancer landscape? Dr. Patel joins The Oncology Brothers to discuss in-depth how to treat cutaneous melanoma using a treatment algorithm. Dr. Jeff Sharman discusses the nuances of CLL management and how to treat the disease using an algorithm. The Oncology Brothers speak with Cathy Eng, MD, about treatment of metastatic colorectal cancer with fruquintinib. Jill Feldman, a lung cancer survivor and co-founder of the EGFR Resisters advocacy group, details her lung cancer journey. Dr. S. Vincent Rajkumar and The Oncology Brothers develop an algorithm for patients with MGUS or smoldering multiple myeloma. Dr. Jens Hillengass joins The Oncology Brothers to discuss an algorithm for treating multiple myeloma.